Safety and efficacy of ultrasound-guided intra-articular hylan G-F 20 injection in osteoarthritis of the hip: a pilot study.
OBJECTIVE
The aim of this study was to determine the efficacy and safety of viscosupplementation applied to the hip joint with the lateral approach and ultrasound guidance and to show whether this can be an alternative treatment model in hip osteoarthritis (OA).


METHODS
We performed three hylan G-F injections each to 14 patients with hip OA. We evaluated visual analog score (VAS), Lequesne hip OA severity index, 15-meter walking time before injections and 30 and 90 days after injections, and patient satisfaction.


RESULTS
We established that after 30 respectively 90 days of treatment, VAS, Lequesne hip OA severity index, and 15-meter walking time were statistically significantly lower than before the treatment. This decrease continued after the 30th day. No side effects or complications were observed.


CONCLUSIONS
Viscosupplementation performed under ultrasound guidance with the lateral approach is an effective and safe method and can be an alternative treatment of hip OA.
Caglar-Yagci
Hanife
H
Physical Medicine and Rehabilitation Department, Ankara Physical Medicine and Rehabilitation Education and Research Hospital, Ankara, Turkey. drcaglar@yahoo.com
Unsal
Sibel
S
Yagci
Ilker
I
Dulgeroglu
Deniz
D
Ozel
Sumru
S
D005260:Female; D006304:Health Status; D006621:Hip Joint / Q000000981:diagnostic imaging / Q000187:drug effects; D006801:Humans; D006820:Hyaluronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D007270:Injections, Intra-Articular; D008297:Male; D015207:Osteoarthritis, Hip / Q000188:drug therapy* / Q000503:physiopathology; D010045:Outpatients; D010146:Pain / Q000188:drug therapy; D010147:Pain Measurement; D010865:Pilot Projects; D012720:Severity of Illness Index; D016896:Treatment Outcome; D014463:Ultrasonography; D016138:Walking
C049816:hylan; D006820:Hyaluronic Acid